ArticleCytometry. Part B, Clinical cytometry2021

CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab.

Kah Teong Soh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.